LGND earnings call for the period ending March 30, 2019.
News & Analysis: Ligand Pharmaceuticals
Looking for potential winning biotech stocks? These five check off all the boxes for investors.
Investors are not impressed with the company's plan to finance an acquisition spree.
LGND earnings call for the period ending December 31, 2018.
When Citron speaks, investors listen -- but should they?
Find out why a medical device maker, a gene sequencer, and a drug licensing company have our team of healthcare experts feeling bullish.
LGND earnings call for the period ending September 30, 2018.
It's been a tough month for these top healthcare stocks, which means it's time to go shopping.
Adding these biotech stocks to portfolios at current prices could pay off.
This trio is not big or small, but each offers investors a potentially huge long-term investment opportunity...if you take action right now.